ArticlePloS one2026
Could molecular variations be predictive in right and left colon cancer in different gender and age groups?
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeft-sided colon-cancer (LCC) and right-sided colon cancer (RCC) harbor different clinical entities and different therapy protocols. Our study aimed to demonstrate genomic expression differences and clarify the clinical differences between LCC and RCC by using in-silico methods.
methodsOur study compares mRNA expression levels between clinical groups to describe variations in molecular characteristics between right-left-sided colon cancer (216 right-141 left) using the TCGA-COAD database. We identified differentially expressed genes and analyzed survival profiles for RCC and LCC. We applied a gene set enrichment analysis and merged the results by group to highlight common and different pathways.
resultsThe results reveal that TG, INSL5, EREG and AIRE were found as age-related genes, and TG, INSL5, EREG, AIRE, HOXB8 and FLT3 were found as gender-related genes for RCC and LCC. We found that high expression of the AIRE gene was linked with poor survival in patients with RCC in males and under 65 age groups. High expression of LEP was correlated with poor survival in patients with RCC, regardless of gender. In addition, low expression of the EREG gene was linked with poor survival in women with RCC.
conclusionsThree genes (AIRE, LEP, EREG), which are effective on the EGFR pathway, would have great predictive and prognostic importance in the context of anti-EGFR therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.